Opdivo 240 MG/24 ML vial 24ML
Ended Awarded
- Contract number
- SPE2DB26FX3PZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,907
Award facts
- Contract value 100% obligated
- $14,906.79 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of OPDIVO 240 mg/24 mL vials, an immuno-oncology pharmaceutical product. This firm fixed price delivery order, valued at $14,906.79, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999 and extending through December 2026. The order is scheduled for completion by November 12, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. No set-aside designation was applied to this award, indicating it was competitively awarded.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills a critical role in the federal medical procurement supply chain through its extensive portfolio of brand-name and generic medications, vaccines, and medical supplies. The DLA Troop Support Medical IDC enables the company to supply pharmaceuticals and medical commodities to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. This particular delivery order for OPDIVO, a specialized cancer immunotherapy medication, reflects the company's capability to provide specialized medical products essential to federal healthcare systems supporting military personnel and veterans.
Quick answers
Who was awarded contract SPE2DB26FX3PZ?
SPE2DB26FX3PZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 21, 2025.
How much is contract SPE2DB26FX3PZ worth?
The government has obligated $14,907 on SPE2DB26FX3PZ.
Is contract SPE2DB26FX3PZ an order under another contract?
Yes. SPE2DB26FX3PZ is a delivery order under SPE2DB22D3301, an indefinite delivery contract.
Was contract SPE2DB26FX3PZ competed?
The extent of competition for SPE2DB26FX3PZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award